Levetiracetam intravenous infusion: A randomised placebo-controlled safety study.

被引:0
|
作者
Ramael, S
Troenaru, M
Toublanc, N
Daoust, A
Otoul, C
Lu, Z
Stockis, A
机构
[1] SGS Biopharma SA, Antwerp, Belgium
[2] UCB Pharma Inc, Smyrna, GA USA
[3] UCB Bioprod SA, Braine Lalleud, Belgium
关键词
D O I
10.1016/j.clpt.2005.12.289
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P81 / P81
页数:1
相关论文
共 50 条
  • [1] Levetiracetam intravenous infusion: a randomized placebo-controlled safety study
    Troenaru, M.
    Ramael, S.
    Toublanc, N.
    Daoust, A.
    Otoul, C.
    Lu, Z.
    Stockis, A.
    [J]. EPILEPSIA, 2007, 48 : 109 - 109
  • [2] Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study
    Ramael, Steven
    Daoust, Agnes
    Otoul, Christian
    Toublanc, Nathalie
    Troenaru, Mona
    Lu, Zhihong
    Stockis, Armel
    [J]. EPILEPSIA, 2006, 47 (07) : 1128 - 1135
  • [3] Intravenous infusion of lidocaine significantly reduces propofol dose for colonoscopy: a randomised placebo-controlled study
    Forster, C.
    Vanhaudenhuyse, A.
    Gast, P.
    Louis, E.
    Hick, G.
    Brichant, J-F
    Joris, J.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2018, 121 (05) : 1059 - 1064
  • [4] Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
    Rohit Aggarwal
    Joachim Schessl
    Christina Charles-Schoeman
    Zsuzsanna Bata-Csörgő
    Mazen M. Dimachkie
    Zoltan Griger
    Sergey Moiseev
    Chester V. Oddis
    Elena Schiopu
    Jiri Vencovský
    Irene Beckmann
    Elisabeth Clodi
    Todd Levine
    [J]. Arthritis Research & Therapy, 26
  • [5] Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
    Aggarwal, Rohit
    Schessl, Joachim
    Charles-Schoeman, Christina
    Bata-Csorgo, Zsuzsanna
    Dimachkie, Mazen M.
    Griger, Zoltan
    Moiseev, Sergey
    Oddis, Chester V.
    Schiopu, Elena
    Vencovsky, Jiri
    Beckmann, Irene
    Clodi, Elisabeth
    Levine, Todd
    [J]. ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [6] Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
    Berkovic, S. F.
    Knowlton, R. C.
    Leroy, R. F.
    Schiemann, J.
    Falter, U.
    [J]. NEUROLOGY, 2007, 69 (18) : 1751 - 1760
  • [7] Safety, tolerability and pharmacokinetics of levetiracetam intravenous infusion
    Stockis, A.
    Toublanc, N.
    Ramael, S.
    De Smedt, F.
    Otoul, C.
    Boulanger, P.
    Riethuisen, J. M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 232 - 232
  • [8] Safety, tolerability, and pharmacokinetics of levetiracetam intravenous infusion
    Stockis, A.
    Toublanc, N.
    Ramael, S.
    De Smedt, F.
    Otoul, C.
    Boulanger, P.
    Riethuisen, J.
    [J]. EPILEPSIA, 2007, 48 : 107 - 108
  • [9] Interaction between paracetamol and warfarin: A double-blind placebo-controlled randomised study.
    Mahe, I
    Bertrand, N
    Drouet, L
    Simoneau, G
    Sollier, CBD
    Mazoyer, E
    Caulin, C
    Bergmann, JF
    [J]. BLOOD, 2005, 106 (11) : 119B - 119B
  • [10] DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF LEVETIRACETAM FOR STATUS EPILEPTICUS
    Patterson, Edward E.
    Cloyd, J. C.
    Mcvey, A.
    Hardy, R.
    Craig, A.
    Dunn, A.
    Olmstead, B.
    Rarick, J.
    Leppik, I.
    [J]. EPILEPSIA, 2008, 49 : 104 - 104